Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
This study aimed to evaluate the association of serum 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels with clinical severity and mortality among hospitalized patients with moderate and severe COVID-19.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This retrospective observational cohort study included adult patients (≥18 years) who were hospitalized with confirmed SARS-CoV-2 infection by polymerase chain reaction (PCR) between March and May 2020.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients
Cohort study · Frontiers in Nutrition · 2026
Original publication title
Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients
Copyright © 2026 Canbolat Unlu, Karabela, Yesilbag, Korkusuz, Borcak, Salim Dogdas, Senoglu, Isiksacan and Kart Yasar.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
This study aimed to evaluate the association of serum 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels with clinical severity and mortality among hospitalized patients with moderate and severe COVID-19.
Source: BackgroundAbstract: What methods does the paper describe?
A total of 185 adult patients (≥18 years) with confirmed SARS-CoV-2 PCR positivity and without chronic kidney disease, admitted between March and May 2020, were included. Clinical characteristics, laboratory parameters, and serum 25(OH)D and 1,25(OH)2D levels were assessed. Factors associated with severe disease and mortality were determined using multivariate logistic regression and Cox regression analyses.
Source: MethodsAbstract: Results
Of the patients, 114 had moderate disease and 71 had severe disease. Length of hospital stay, intensive care unit (ICU) admission, and mortality rates were significantly higher in the severe group. While 25(OH)D levels were lower in the moderate group, 1,25(OH)2D levels were markedly reduced in severe cases. Multivariate analysis identified prolonged hospital stay, ICU admission history, and low 1,25(OH)2D levels were independently associated with severe disease. Independently associated factors with mortality were ICU admission (p < 0.001), high troponin levels (p = 0.003) and prolonged activated partial thromboplastin time (APTT) (p = 0.04).
Although vitamin D deficiency was associated with severe disease, it was not independently associated with mortality.
Source: ResultsAbstract: Conclusion
Reduced 1,25(OH)2D levels are associated with severe COVID-19 and may serve as a meaningful biomarker for predicting disease severity. These findings suggest that assessing 1,25(OH)2D levels may support clinical decision-making, particularly in patients at risk for severe COVID-19 or ARDS.
Source: ConclusionAuthors’ abstract
Background
This study aimed to evaluate the association of serum 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels with clinical severity and mortality among hospitalized patients with moderate and severe COVID-19.
Methods
A total of 185 adult patients (≥18 years) with confirmed SARS-CoV-2 PCR positivity and without chronic kidney disease, admitted between March and May 2020, were included. Clinical characteristics, laboratory parameters, and serum 25(OH)D and 1,25(OH)2D levels were assessed. Factors associated with severe disease and mortality were determined using multivariate logistic regression and Cox regression analyses.
Results
Of the patients, 114 had moderate disease and 71 had severe disease. Length of hospital stay, intensive care unit (ICU) admission, and mortality rates were significantly higher in the severe group. While 25(OH)D levels were lower in the moderate group, 1,25(OH)2D levels were markedly reduced in severe cases. Multivariate analysis identified prolonged hospital stay, ICU admission history, and low 1,25(OH)2D levels were independently associated with severe disease. Independently associated factors with mortality were ICU admission (p < 0.001), high troponin levels (p = 0.003) and prolonged activated partial thromboplastin time (APTT) (p = 0.04).
Although vitamin D deficiency was associated with severe disease, it was not independently associated with mortality.
Conclusion
Reduced 1,25(OH)2D levels are associated with severe COVID-19 and may serve as a meaningful biomarker for predicting disease severity. These findings suggest that assessing 1,25(OH)2D levels may support clinical decision-making, particularly in patients at risk for severe COVID-19 or ARDS.
Publication and source details
Original title: Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients
Esra Canbolat Unlu; Semsi Nur Karabela; Zuhal Yesilbag; Ramazan Korkusuz; Deniz Borcak; Esra Salim Dogdas; Sevtap Senoglu; Nilgun Isiksacan; Kadriye Kart Yasar
Frontiers in Nutrition · 2026
* Correspondence: Esra Canbolat Unlu, esracanbolat@gmail.comThese authors have contributed equally to this work
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:21:13.593884+00:00
DOI: 10.3389/fnut.2026.1836021 · PMC13279753